Clik here to view.
欧州委員会が武田薬品のALUNBRIG®（ブリガチニブ）をALK+ NSCLCのファーストライン治療薬として承認
米マサチューセッツ州ケンブリッジ & 大阪 （ビジネスワイヤ） —...
View ArticleClik here to view.
ReForm Biologics Announces the Issuance of U.S. and Japanese Patents for...
WOBURN, Mass. ReForm Biologics, a pharmaceutical technology company developing innovative biologic formulations to improve drug delivery and manufacturing, expanded its patent portfolio with the...
View ArticleClik here to view.
Arrowhead Pharmaceuticals Files for Regulatory Clearance to Begin Phase 1/2a...
PASADENA, Calif. Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) today announced that it has filed an application for clearance to begin a Phase 1/2a clinical trial of ARO-ENaC, the company’s...
View ArticleClik here to view.
Celltrion Completes Neutralisation Test on Candidate Monoclonal Antibodies...
INCHEON, Korea Celltrion Group today announced that the company has successfully selected the most potent antibody candidates to neutralise SARS-CoV-2, the virus causing COVID-19. This press release...
View ArticleClik here to view.
MEI Pharma and Kyowa Kirin Announce Global License, Development and...
SAN DIEGO & TOKYO MEI Pharma, Inc. (NASDAQ: MEIP) and Kyowa Kirin Co., Ltd. (Kyowa Kirin, TOKYO: 4151) today jointly announced that the companies have entered into a global license, development...
View ArticleClik here to view.
Propanc Biopharma Receives First Allowance for Key Patent Family from...
MELBOURNE, Australia Propanc Biopharma, Inc. (OTC:PPCB) (“Propanc” or the “Company”), a biopharmaceutical company developing new cancer treatments for patients suffering from recurring and...
View ArticleClik here to view.
Cyclica Forms Multi-Year and Multi-Project Drug Discovery Partnership with...
TORONTO & SINGAPORE Cyclica announces a multi-year and multi-project collaboration with the Genome Institute of Singapore (GIS), a research institute under the Agency for Science, Technology and...
View ArticleClik here to view.
Sinovac Announces Approval of Human Clinical Trial for a Vaccine Candidate...
BEIJING Sinovac Biotech Ltd. (NASDAQ:SVA) (“Sinovac” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that the Company has obtained approval to conduct a...
View ArticleClik here to view.
Hansoh Expands AI Partnership with Atomwise after Early Success for Key...
SHANGHAI & SAN FRANCISCO Hansoh Pharma (3692:HK), a leading biopharmaceutical company in China, and Atomwise, the leader in artificial intelligence (AI) for drug discovery, today announced the...
View ArticleClik here to view.
Northern Data：人工智能领导者Innoplexus选择Northern Data HPC解决方案来加快针对COVID-19的药物研究和开发
德国法兰克福 (美国商业资讯)–全球最大的高性能计算(HPC)解决方案提供商之一Northern Data AG (XETRA: NB2, ISIN: DE000A0SMU87)今日宣布与Innoplexus AG缔结战略合作关系，以加快针对COVID-19及其他疾病的药物研究和开发。...
View ArticleClik here to view.
Biolytic推出Dr. Oligo 768XLc DNA RNA合成仪——合成768 Oligos变得更快
加州弗里蒙特 (美国商业资讯)–Biolytic Lab Performance Inc.推出其新型寡核苷酸合成仪Dr. Oligo 768XLc，这是用于高通量核酸合成的最先进的商业平台。该合成仪旨在用于研发和生产设施，满足那些专注于各种病毒、疾病和病况诊断和治疗应用的组织的需求，在这些组织中，大量独特的DNA和RNA对他们的产品、服务和进行中的研究至关重要。...
View ArticleClik here to view.
Samsung Bioepis Announces US Launch of ONTRUZANT® (trastuzumab-dttb) for...
INCHEON, Korea Samsung Bioepis Co., Ltd. announced today that ONTRUZANT® (trastuzumab-dttb), a biosimilar of the reference biologic medicine HERCEPTIN®1 (trastuzumab) for the treatment of...
View ArticleClik here to view.
バイオリティックが768本のオリゴヌクレオチド合成を迅速化するDNA／RNA合成装置のDr. Oligo 768XLcを発表
米カリフォルニア州フリーモント （ビジネスワイヤ） — バイオリティック・ラボ・パフォーマンスは新規オリゴヌクレオチド合成装置のDr. Oligo...
View ArticleClik here to view.
ノーザン・データ：AIリーダー企業のイノプレクサスがノーザン・データのHPCソリューションを選定してCOVID-19と闘うための創薬・医薬品開発を加速
独フランクフルト （ビジネスワイヤ） — ハイパフォーマンス・コンピューティング（HPC）ソリューションを提供する世界最大級の企業のノーザン・データ（XETRA：NB2、ISIN：DE000A0SMU87）は本日、イノプレクサスとの戦略的提携について発表します。COVID-19およびその他の疾患を対象に創薬と医薬品開発を加速化させることが目的です。...
View ArticleClik here to view.
How Propanc Biopharma Is Joining the Fight with Cancer Patients Who Are...
MELBOURNE, Australia Propanc Biopharma, Inc. (OTC: PPCB) (“Propanc” or the “Company”), a biopharmaceutical company developing new cancer treatments for patients suffering from recurring and...
View ArticleClik here to view.
LegoChem Biosciences and Iksuda Enter into a Multi-Target Research...
DAEJEON, South Korea LegoChem Biosciences, Inc. (“LCB”) (KOSDAQ:141080), based in Daejeon, South Korea, announced today that it has entered a research collaboration and license agreement with Iksuda...
View ArticleClik here to view.
Sinovac Announces Commencement of Phase I Human Clinical Trial for Vaccine...
BEIJING Sinovac Biotech Ltd. (NASDAQ:SVA) (“Sinovac” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that the Company has commenced Phase I clinical...
View ArticleClik here to view.
Promega Successfully Completes First Fully Remote Quality Surveillance...
MADISON, Wis. Promega Corporation announced today it successfully completed its first ever fully remote quality surveillance assessment and is recommended for continued certification to ISO...
View ArticleAVITA Medical Announces Intention to Redomicile to the United States of America
VALENCIA, Calif. & MELBOURNE, Australia AVITA Medical Limited (Company) (ASX: AVH, NASDAQ: RCEL), a regenerative medicine company with a technology platform positioned to address unmet medical...
View ArticleClik here to view.
Genetron Health Announces Forthcoming Unveiling of Its Cancer Research Papers...
BEIJING Genetron Holdings Limited (“Genetron Health”), a China-based precision oncology company that covers full-cycle cancer care, announced that 14 cancer research papers will be presented as...
View Article